Research Organization
type: Class

Anualidad
type: Class

Research Activity Report
type: Class

2017
type: Class

RDF description of Moléculas bioactivas 2017 - http://research.umh.es/vivo/pub/memoria/2017/gi_1079
type: Document
rights: termsOfUse
date: 2026-08-31T11:47:08
publisher: Moléculas bioactivas 2017

Moléculas bioactivas 2017
type: Research Activity Report
includes: IX JORNADAS SAN ALBERTO MAGNO (Congress Organization)
includes: LIPOTEC1.14D
includes: Sphingosine-1-Phosphate and the S1P3 Receptor Initiate Neuronal Retraction via RhoA/ROCK Associated with CRMP2 Phosphorylation
includes: Differential binding of monovalent cations to KcsA: Deciphering the mechanisms of potassium channel selectivity
includes: 2017/00381/001
includes: In silico design of new TRAAK ion channel modulators for the treatment of chronic pain
most specific type: 2017
includes: Diseño in silico de nuevos moduladores del canal iónico TRAAK para el tratamiento de dolor crónico
most specific type: Research Organization
includes: AVIZOREXCSIC113ET
included: Moléculas bioactivas
includes: Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of alpha 7 nicotinic receptors with analgesic activity
includes: DIVERDRUGS1.17D
includes: SAF2015-66275-C2-1-R
includes: http://research.umh.es/vivo/pub/comunicacion/187621
includes: INDICO2017/ORGANIZA12
type: Anualidad
includes: INDICO2017-DIVULGA/053
type: Research Organization
includes: Lipids as central modulators of sensory TRP channels.
relates: Moléculas bioactivas
includes: FERNÁNDEZ BALLESTER, GREGORIO JOAQUIN
includes: ANTALGENICS3.16A
type: Thing
includes: ANTALGENICS4.16D
includes: INNOVA+2016-DIVULGA/105
type: 2017
includes: LIPOTEC2.16R
includes: FERRER MONTIEL, ANTONIO VICENTE
includes: ALODIA1.17LP
includes: Synthesis, high-throughput screening and pharmacological characterization of ß-lactam derivatives as TRPM8 antagonists
includes: AVIZOREX1.16LP
includes: Entrepreneurship, moving away from academia
includes: Selective exclusion and selective binding both contribute to ion selectivity in KcsA, a model potassium channel
includes: FERNÁNDEZ CARVAJAL, ASIA
includes: FASTBASE1.16ET
includes: Tryptamine-based derivatives as new TRPM8 modulators: in vitro and in vivo activity.
includes: PROSPERABIOTECH1.16ET
includes: INDICO2017/ORGANIZA13
includes: ANTALGENICS2.17D
includes: LIPOTEC1.99R
includes: PROMETEOII/2014/011
includes: DIVERDRUGS1.16D
includes: CRIBADO FARMACOLÓGICO PARA EL SÍNDROME DE DRAVET
includes: ANTALGENICS1.15ET
includes: INNOVA+2016-DIVULGA/109
includes: BFU2015-70067-REDC
includes: INDICO2017/CUENTA030
includes: OSMOSIS2016/04
includes: INNOVA+2016-DIVULGA/108

IX JORNADAS SAN ALBERTO MAGNO (Congress Organization)
type: Thing
included: Moléculas bioactivas 2017
type: BFO_0000001
type: BFO_0000015
type: 2017
type: Anualidad
type: Event
type: BFO_0000003
type: ConferenceOrganization

LIPOTEC1.14D
type: BFO_0000001
type: Anualidad
type: BFO_0000002
type: ExplotacionLicencia
type: 2017
included: Moléculas bioactivas 2017
type: BFO_0000020
type: Grant
type: Year2018
type: Project
type: Year2019
type: Thing
type: BFO_0000003
type: Relationship
type: TransferenciaTecnologica
type: BFO_0000015
type: Proyecto

Sphingosine-1-Phosphate and the S1P3 Receptor Initiate Neuronal Retraction via RhoA/ROCK Associated with CRMP2 Phosphorylation
type: BFO_0000002
type: 2017
type: Article
included: Moléculas bioactivas 2017
type: BFO_0000031
type: IAO_0000030
type: Anualidad
type: AcademicArticle
type: Thing
type: Document
type: BFO_0000001

Differential binding of monovalent cations to KcsA: Deciphering the mechanisms of potassium channel selectivity
type: BFO_0000031
type: BFO_0000002
type: BFO_0000001
included: Moléculas bioactivas 2017
type: Document
type: Anualidad
type: 2017
type: IAO_0000030
type: Article
type: Thing
type: AcademicArticle

2017/00381/001
type: Proyecto
type: Thing
type: ProyectoInvestigacion
type: 2017
type: ERO_0000014
type: BFO_0000020
type: Relationship
included: Moléculas bioactivas 2017
type: BFO_0000001
type: Project
type: Grant
type: BFO_0000003
type: OBI_0000011
type: Anualidad
type: BFO_0000002
type: BFO_0000015

In silico design of new TRAAK ion channel modulators for the treatment of chronic pain
type: IAO_0000030
type: Article
type: ConferencePaper
type: BFO_0000031
type: Document
type: Anualidad
type: BFO_0000002
type: Thing
type: Conference
type: BFO_0000001
type: 2017
included: Moléculas bioactivas 2017

Diseño in silico de nuevos moduladores del canal iónico TRAAK para el tratamiento de dolor crónico
type: Anualidad
type: Thing
type: Conference
type: BFO_0000031
type: 2017
included: Moléculas bioactivas 2017
type: BFO_0000002
type: Document
type: ConferencePoster
type: BFO_0000001
type: IAO_0000030

Moléculas bioactivas
type: BFO_0000004
type: ResearchOrganization
type: BFO_0000001
type: ResearchOrganizationActive
type: Organization
related by: Moléculas bioactivas 2017
includes: Moléculas bioactivas 2017
type: Agent
type: BFO_0000002
type: Thing

Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of alpha 7 nicotinic receptors with analgesic activity
type: Document
type: IAO_0000030
type: 2017
type: Article
type: AcademicArticle
included: Moléculas bioactivas 2017
type: BFO_0000031
type: BFO_0000002
type: Anualidad
type: BFO_0000001
type: Thing

DIVERDRUGS1.17D
type: Relationship
type: Project
type: BFO_0000001
included: Moléculas bioactivas 2017
type: BFO_0000003
type: Grant
type: Thing
type: Year2018
type: ProyectoTerceros
type: ERO_0000014
type: BFO_0000015
type: Anualidad
type: BFO_0000002
type: BFO_0000020
type: 2017
type: OBI_0000011
type: ProyectoInvestigacion
type: Proyecto

SAF2015-66275-C2-1-R
type: BFO_0000003
type: Grant
type: ERO_0000014
type: Thing
type: OBI_0000011
type: Proyecto
type: BFO_0000020
type: ProyectoInvestigacion
type: Relationship
type: Year2018
type: Anualidad
type: BFO_0000015
type: Year2019
type: Project
type: 2017
type: BFO_0000001
type: BFO_0000002
included: Moléculas bioactivas 2017

http://research.umh.es/vivo/pub/comunicacion/187621
type: Document
type: IAO_0000030
type: Anualidad
type: BFO_0000001
label: La inhibición de PTK6 potencia los efectos del anticuerpo anti EGFR cetuximab y de los inhibidores de la actividad tirosin kinasas del receptor sobre la proliferación de células tumorales pancreáticas.
type: BFO_0000031
type: Conference
type: BFO_0000002
type: ConferencePoster
type: Thing
type: 2017
included: Moléculas bioactivas 2017

INDICO2017/ORGANIZA12
type: Grant
type: Project
type: OBI_0000011
type: BFO_0000003
type: Relationship
included: Moléculas bioactivas 2017
type: ProyectoInvestigacion
type: 2017
type: BFO_0000020
type: ERO_0000014
type: Thing
type: BFO_0000002
type: Anualidad
type: BFO_0000001
type: BFO_0000015
type: Proyecto

INDICO2017-DIVULGA/053
type: Thing
type: Proyecto
type: OBI_0000011
type: BFO_0000001
type: BFO_0000003
type: Anualidad
type: BFO_0000002
type: BFO_0000020
type: BFO_0000015
type: Grant
type: Project
type: 2017
type: Relationship
included: Moléculas bioactivas 2017
type: ERO_0000014
type: ProyectoInvestigacion

Lipids as central modulators of sensory TRP channels.
type: BFO_0000002
type: 2017
type: Anualidad
type: IAO_0000030
type: Document
type: Thing
type: AcademicArticle
type: BFO_0000001
type: BFO_0000031
type: Article
included: Moléculas bioactivas 2017

FERNÁNDEZ BALLESTER, GREGORIO JOAQUIN
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Moléculas bioactivas 2017

ANTALGENICS3.16A
type: BFO_0000002
included: Moléculas bioactivas 2017
type: Prestacion
type: Relationship
type: Thing
type: Anualidad
type: BFO_0000015
type: Year2016
type: ProyectoApoyoTecnologico
type: Project
type: BFO_0000003
type: BFO_0000020
type: 2017
type: Grant
type: Proyecto
type: BFO_0000001

ANTALGENICS4.16D
type: Grant
type: Proyecto
type: BFO_0000003
type: ProyectoApoyoTecnologico
type: Relationship
type: Year2016
type: Prestacion
type: 2017
type: BFO_0000001
type: BFO_0000020
type: BFO_0000002
type: Thing
type: Project
type: BFO_0000015
included: Moléculas bioactivas 2017
type: Anualidad

INNOVA+2016-DIVULGA/105
type: Grant
type: Thing
type: BFO_0000015
type: BFO_0000020
type: ProyectoInvestigacion
type: ERO_0000014
type: 2017
type: OBI_0000011
type: Proyecto
type: BFO_0000001
type: Relationship
type: Project
type: BFO_0000002
type: Anualidad
type: BFO_0000003
included: Moléculas bioactivas 2017

LIPOTEC2.16R
type: 2017
type: TransferenciaTecnologica
type: BFO_0000015
type: BFO_0000002
type: BFO_0000020
type: Year2020
type: BFO_0000001
type: Year2019
type: Grant
included: Moléculas bioactivas 2017
type: BFO_0000003
type: Thing
type: Anualidad
type: Project
type: ExplotacionLicencia
type: Relationship
type: Year2018
type: Proyecto

FERRER MONTIEL, ANTONIO VICENTE
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Moléculas bioactivas 2017

ALODIA1.17LP
type: Year2019
type: Year2020
type: Grant
type: Year2021
type: Project
type: BFO_0000002
type: ExplotacionLicencia
type: Proyecto
type: 2017
type: Year2018
type: Anualidad
type: Relationship
type: Thing
type: BFO_0000001
type: BFO_0000015
included: Moléculas bioactivas 2017
type: TransferenciaTecnologica
type: BFO_0000003
type: BFO_0000020

Synthesis, high-throughput screening and pharmacological characterization of ß-lactam derivatives as TRPM8 antagonists
type: IAO_0000030
type: Article
type: Thing
type: Document
type: BFO_0000031
type: BFO_0000001
type: Anualidad
type: BFO_0000002
type: 2017
type: AcademicArticle
included: Moléculas bioactivas 2017

AVIZOREX1.16LP
type: 2017
type: Year2020
type: BFO_0000003
type: BFO_0000002
type: TransferenciaTecnologica
type: Grant
type: Year2018
type: Relationship
type: Proyecto
type: ExplotacionLicencia
type: Year2019
type: Year2021
type: BFO_0000020
type: Project
included: Moléculas bioactivas 2017
type: Thing
type: BFO_0000015
type: Anualidad
type: BFO_0000001

Entrepreneurship, moving away from academia
type: Event
type: InvitedTalk
type: InvitedConference
type: BFO_0000015
type: BFO_0000003
type: Thing
type: 2017
type: BFO_0000001
type: Anualidad
type: Presentation
included: Moléculas bioactivas 2017

Selective exclusion and selective binding both contribute to ion selectivity in KcsA, a model potassium channel
type: Document
included: Moléculas bioactivas 2017
type: BFO_0000001
type: Thing
type: BFO_0000031
type: Anualidad
type: IAO_0000030
type: AcademicArticle
type: 2017
type: BFO_0000002
type: Article

FERNÁNDEZ CARVAJAL, ASIA
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Moléculas bioactivas 2017

FASTBASE1.16ET
type: Anualidad
type: TransferenciaTecnologica
type: Year2016
type: ExplotacionLicencia
type: BFO_0000015
type: BFO_0000002
type: Year2020
type: BFO_0000003
type: BFO_0000020
included: Moléculas bioactivas 2017
type: Project
type: Proyecto
type: Grant
type: Year2019
type: BFO_0000001
type: Year2018
type: Year2021
type: Relationship
type: Thing
type: 2017

Tryptamine-based derivatives as new TRPM8 modulators: in vitro and in vivo activity.
type: IAO_0000030
type: Conference
type: BFO_0000031
type: Document
type: Thing
included: Moléculas bioactivas 2017
type: ConferencePoster
type: BFO_0000001
type: BFO_0000002
type: Anualidad
type: 2017

PROSPERABIOTECH1.16ET
type: Year2021
type: Year2018
type: Year2016
type: BFO_0000001
type: BFO_0000020
type: Project
type: Year2019
type: Anualidad
type: 2017
type: TransferenciaTecnologica
type: BFO_0000002
type: BFO_0000003
type: Grant
included: Moléculas bioactivas 2017
type: Relationship
type: Proyecto
type: Year2020
type: Thing
type: BFO_0000015
type: ExplotacionLicencia

INDICO2017/ORGANIZA13
type: Project
included: Moléculas bioactivas 2017
type: ERO_0000014
type: BFO_0000003
type: OBI_0000011
type: Anualidad
type: Relationship
type: BFO_0000020
type: Grant
type: BFO_0000002
type: ProyectoInvestigacion
type: 2017
type: BFO_0000001
type: BFO_0000015
type: Proyecto
type: Thing

ANTALGENICS2.17D
type: Thing
type: BFO_0000001
type: Prestacion
included: Moléculas bioactivas 2017
type: Proyecto
type: Relationship
type: Anualidad
type: Grant
type: ProyectoApoyoTecnologico
type: BFO_0000003
type: BFO_0000002
type: BFO_0000015
type: 2017
type: BFO_0000020
type: Project

LIPOTEC1.99R
type: Grant
type: Year2015
type: BFO_0000002
type: Thing
type: Year2008
type: Year2013
type: Year2010
included: Moléculas bioactivas 2017
type: Year2006
type: Year2016
type: BFO_0000003
type: Year2018
type: Relationship
type: Anualidad
type: Year2004
type: Year2009
type: Year2011
type: Project
type: TransferenciaTecnologica
type: BFO_0000001
type: Year2014
type: BFO_0000015
type: ExplotacionLicencia
type: Year2020
type: 2017
type: Proyecto
type: Year2019
type: Year2005
type: Year2012
type: Year2007
type: BFO_0000020
type: Year2000

In silico design of new TRAAK ion channel modulators for the treatment of chronic pain
type: Anualidad
type: Thing
included: Moléculas bioactivas 2017
type: Conference
type: BFO_0000031
type: 2017
type: Document
type: BFO_0000002
type: IAO_0000030
type: ConferencePoster
type: BFO_0000001

PROMETEOII/2014/011
type: BFO_0000015
type: Proyecto
type: ERO_0000014
type: 2017
type: Anualidad
type: Relationship
type: ProyectoInvestigacion
type: OBI_0000011
type: Grant
type: Project
type: BFO_0000001
type: Thing
type: BFO_0000002
type: BFO_0000020
type: BFO_0000003
included: Moléculas bioactivas 2017

DIVERDRUGS1.16D
type: OBI_0000011
type: Relationship
type: 2017
type: BFO_0000020
type: Year2016
type: Project
type: ProyectoTerceros
included: Moléculas bioactivas 2017
type: Anualidad
type: BFO_0000003
type: Proyecto
type: BFO_0000002
type: Thing
type: BFO_0000001
type: ERO_0000014
type: ProyectoInvestigacion
type: BFO_0000015
type: Grant

CRIBADO FARMACOLÓGICO PARA EL SÍNDROME DE DRAVET
type: Thing
type: Anualidad
type: 2017
type: TesisDoctoral
type: Document
type: BFO_0000001
type: BFO_0000002
type: BFO_0000031
included: Moléculas bioactivas 2017
type: Thesis
type: IAO_0000030

ANTALGENICS1.15ET
type: ExplotacionLicencia
type: Year2020
type: Year2021
type: BFO_0000020
type: Year2023
type: Year2018
type: Project
included: Moléculas bioactivas 2017
type: Year2016
type: BFO_0000001
type: Grant
type: Relationship
type: Year2015
type: TransferenciaTecnologica
type: Anualidad
type: BFO_0000003
type: Proyecto
type: Year2019
type: Thing
type: 2017
type: BFO_0000002
type: BFO_0000015
type: Year2022

INNOVA+2016-DIVULGA/109
type: ProyectoInvestigacion
included: Moléculas bioactivas 2017
type: Relationship
type: 2017
type: BFO_0000015
type: BFO_0000003
type: Grant
type: BFO_0000020
type: BFO_0000002
type: Project
type: Proyecto
type: BFO_0000001
type: Anualidad
type: OBI_0000011
type: ERO_0000014
type: Thing

BFU2015-70067-REDC
type: BFO_0000001
type: BFO_0000020
type: Year2018
type: BFO_0000003
included: Moléculas bioactivas 2017
type: 2017
type: BFO_0000002
type: Anualidad
type: BFO_0000015
type: Grant
type: ProyectoInvestigacion
type: Relationship
type: OBI_0000011
type: Proyecto
type: Project
type: ERO_0000014
type: Thing

INDICO2017/CUENTA030
type: Project
type: Thing
type: Relationship
type: Grant
type: 2017
type: BFO_0000020
type: ERO_0000014
type: BFO_0000015
type: BFO_0000003
type: BFO_0000002
type: OBI_0000011
type: ProyectoInvestigacion
type: Anualidad
type: BFO_0000001
type: Proyecto
included: Moléculas bioactivas 2017

OSMOSIS2016/04
type: Relationship
type: Thing
type: OBI_0000011
type: ERO_0000014
type: Project
type: Grant
type: BFO_0000003
type: BFO_0000020
type: Anualidad
type: BFO_0000015
included: Moléculas bioactivas 2017
type: BFO_0000001
type: Proyecto
type: BFO_0000002
type: ProyectoInvestigacion
type: 2017

INNOVA+2016-DIVULGA/108
type: Anualidad
type: ProyectoInvestigacion
included: Moléculas bioactivas 2017
type: Proyecto
type: BFO_0000001
type: Project
type: BFO_0000015
type: OBI_0000011
type: Thing
type: Relationship
type: BFO_0000003
type: BFO_0000020
type: ERO_0000014
type: Grant
type: 2017
type: BFO_0000002